A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.

Clinical trial NCT06525311 · COMPLETED

Trial details

NCT number: NCT06525311
Sponsor: Kowa Research Institute, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Biliary Cholangitis Compensated Cirrhosis

Start date: 2024-10-01
Primary completion: 2025-03-12
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.